FDA Approved: FONDAPARINUX SODIUM — Original Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approves the Original Application for fondaparinux sodium from Zydus Pharmaceuticals (USA) Inc., a generic anticoagulant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism Prophylaxis After Orthopedic Surgery

Drugs mentioned

• Fondaparinux sodium (Fondaparinux sodium)

Snippet

ORIG AP for FONDAPARINUX SODIUM (FONDAPARINUX SODIUM)